Jenna Bush Hager reveals topless sunbathing once left her chest green — dermatologist reveals why
Here's another reason to slather on some SPF this summer — especially if you're planning to bare it all.
Jenna Bush Hager revealed this week that a trip to a topless beach in Spain during high school left her so scorched, her chest turned green.
'If you get burned, it's not pretty,' the 43-year-old 'Today With Jenna & Friends' co-host told actress Leslie Bibb on Tuesday's episode.
5 Actress Leslie Bibb appeared on the June 16 episode of 'Today With Jenna & Friends.'
NBC
When Bibb, 51, asked if her chest peeled, Bush Hager nodded — but then took things in a bizarre turn.
'They may have turned green,' the TV personality said. 'The opposite of the color wheel!'
'They turned green? Are you for real life?' the White Lotus star gasped.
'Oh, I don't think that's good,' Bibb added — and she's probably right.
Sunburns happen when you're exposed to too much ultraviolet (UV) light, which can penetrate into deep layers of the skin and cause cellular damage, according to the Mayo Clinic.
The body responds by increasing blood flow to the area, leading to inflamed skin we know as a burn.
'Signs that your burns are significant include painful redness, peeling and blisters,' Dr. Lauren Taglia, a dermatologist, told Northwestern Medicine.
In Bush Hager's case, her Elphaba-esque chest may have signaled something more serious going on beneath the surface.
5 Bush Hager's chest 'turned green' after a bad sunburn.
NBC
5 'Green!' Bibb exclaimed. 'That… makes me sick.'
TODAY with Jenna & Friends / TikTok
'When the skin barrier is significantly damaged from a bad sunburn, it's possible to develop a secondary bacterial infection,' Dr. Adarsh Vijay Mudgil, medical director of Mudgil Dermatology, told The Post.
Mudgil hasn't treated Bush Hager personally, but he speculated that her symptoms could be caused by impetigo, a common and contagious bacterial skin infection.
'This can lead to the formation of yellowish-green crusts, which would explain the green color she described,' Mudgil explained.
'Impetigo can be painful and requires antibiotics for treatment, either topical or systemic, depending on how widespread the infection is,' he noted.
Gross? Bush Hager agrees.
5 All skin types can burn, though those with a lighter complexion are more at risk.
Evgen – stock.adobe.com
The former first daughter said the experience was enough to scare her away from sunbathing for good.
'I try not, but this is years of sun damage,' she admitted, rubbing her arms and adding that she now gets regular skin checks.
She also offered some sage advice for viewers: wear sunscreen, especially when you're young.
'SPF babies, SPF! Get hip with it!' Bibb chimed in.
Dermatologists agree. For daily use, most experts recommend using sunscreen with an SPF of at least 30. If you're spending extended time outdoors, SPF 60 or higher is smart, according to Johns Hopkins Medicine.
For full-body coverage, aim for about one ounce of sunscreen — roughly a shot glass. And don't forget to reapply every two hours, or more if you're swimming or sweating.
Even if you're inside, you're not off the hook.
5 Hager Bush, a mom-of-three, wishes her younger self hadn't tanned so much.
Instagram/jennabhager
'Most ultraviolet (UV) rays can penetrate glass, so if you're working or relaxing near a window, you're receiving sun exposure,' Dr. Elisabeth G. Richard, a dermatologist, told the Skin Cancer Foundation.
The bright side: you won't have to reapply as frequently as you would outdoors, likely every four to six hours.
'Sun damage is cumulative,' Richard noted. 'So even if you're only exposed for a short time, it's important to have protection.'
Experts also recommend doubling up with wide-brimmed hats, sunglasses and protective clothing for extra coverage. When the sun's at its peak — between 10 a.m. and 2 p.m. — your best bet is to head for the shade.
And if a green chest isn't warning enough, don't forget: Every sunburn — even a mild one — increases your risk of skin cancer, including melanoma, the deadliest form of all.
In fact, just one blistering burn in childhood or adolescence more than doubles your risk of melanoma later in life, according to the Skin Cancer Foundation.
The American Cancer Society estimates that in 2025, 104,960 new melanoma cases will be diagnosed in the US — and 8,430 Americans will die from it.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
an hour ago
- Medscape
DLBCL: Tumor Cell Signatures Predict CAR-T Success
Traits of noncancerous cells in diffuse large B-cell lymphoma (DLBCL) tumors appear to offer insight into which patients will benefit the most from chimeric antigen receptor (CAR) T-cell therapy, researchers reported at the 18th International Conference on Malignant Lymphoma (ICML) 2025 in Lugano, Switzerland, and in a simultaneously published study in Cancer Cell . An analysis of DLBCL tumor cells led by investigators from MD Anderson Cancer Center in Houston and Washington University School of Medicine in St Louis, Missouri, identified three 'lymphoma microenvironment archetype profiles' — two that are abnormal and one that is in the normal range. The research suggests that 'diffuse large B-cell lymphoma patients who have this normal lymph node environment are those most likely to benefit from CAR T-cell therapy. This may be a very useful predictive biomarker to select patients who would really benefit from this treatment,' said discussant Stephen M. Ansell, MB ChB, PhD, chair of Hematology at Mayo Clinic, Rochester, Minnesota, at an ICML session where the findings were presented. Defining the Lymphoma 'Microenvironment' The researchers launched the study to better understand the lymphoma microenvironment, defined as 'all of the nontumor cells that define the architecture and immune state of DLBCLs,' said co-author Michael R. Green, PhD, associate professor and vice chair for Research, Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, in an interview. 'With the introduction of T-cell engaging therapies and cellular therapies, which are currently used in the relapsed/refractory setting and are likely primarily influenced by the immune microenvironment, we saw a need to provide a comprehensive map of immune and nonimmune cells within DLBCLs,' Green said. The focus, he said, is on 'how they are assembled into reproducible microenvironment archetypes and how these relate to outcome in patients treated with cellular therapy.' Using single-nucleus multiome sequencing, researchers analyzed cells from 232 tumors and 232 control tissues. At the ICML presentation, study co-author David A. Russler-Germain, MD, PhD, instructor, Division of Oncology, Washington University School of Medicine, Siteman Cancer Center/Barnes-Jewish Hospital, St. Louis, Missouri, said three archetypes of cells were identified: FMAC archetype (37% of tumors): 'Characterized by a sparsity of T/K [T/natural killer] cells and an overrepresentation of cancer-associated fibroblasts and macrophages' (37% of tumors): 'Characterized by a sparsity of T/K [T/natural killer] cells and an overrepresentation of cancer-associated fibroblasts and macrophages' LN archetype (33% of tumors): 'Characterized by naive and memory T cells together with lymph node architecture cell types' (33% of tumors): 'Characterized by naive and memory T cells together with lymph node architecture cell types' TEX archetype (30% of tumors): 'Characterized by an abundance of CD8+ T cells with markers of exhaustion' Dramatic Differences in CAR-T Response Rates Researchers applied the data to the ZUMA-7 clinical trial, which compared CAR-T cell therapy to standard chemotherapy, and found signs that the archetypes had predictive power. Patients with the LN archetype — resembling normal lymph node architecture — had the best outcomes with CAR-T therapy, achieving 67% progression-free survival at 1 year. FMAC and TEX archetypes had much lower success rates of 43% and 35%, respectively. 'The key data related to outcome is that LN archetype patients highly benefit from CAR T, FMAC patients have a diminished benefit, but it is still significantly better than standard of care, and TEX patients have no significant benefit to CAR T compared to standard of care,' Green said. 'This is the first biological subgroup of patients shown clearly not to benefit from CAR T with underlying biology that provides direct and targetable mechanisms of resistance.' Implications for Personalized Treatment As the study noted, the introduction of CAR T-cell therapy as a second-line therapy in DLBCL 'has significantly improved outcomes and leads to durable responses beyond 2 years in > 40% of patients. Nevertheless, most patients will not have durable benefit from [CAR T], highlighting a critical need to understand factors influencing response.' According to Green, the findings suggest that CAR T-cell therapy could be tailored for each archetype. 'LN patients will likely have good outcomes with CAR T alone, whereas FMAC patients have a cold microenvironment that may benefit from 'microenvironment priming' prior to CAR T, and TEX patients may require combination of CAR T cells with other agents such as interferon gamma and checkpoint-blocking antibodies.' The study's classification system, known as LymphoMAP, is not yet available in the clinic. However, it 'will be prospectively evaluated in interventional trials using microenvironment-guided therapeutic strategies using CAR-T or bispecific antibodies as a backbone,' Green said. Moving forward, discussant Ansell said, 'there is a great opportunity look at the good outcome group and say, 'What is it about them that causes about half of those patients to subsequently progress or die and not do as well as what we would hope?' How could we make that top group, the responding group, do even better?' This research was funded by the Schweitzer Family, the MD Anderson Lymphoid Malignancies Program and the National Cancer Institute. Green is a scholar of the Leukemia and Lymphoma Society, and two authors are supported by fellowships from the Lymphoma Research Foundation.
Fast Company
19 hours ago
- Fast Company
Ear wax may hold the key to early Parkinson's diagnosis
An unlikely body byproduct may be able to help doctors diagnose Parkinson's Disease early. According to a new Chinese study, which was published in Analytical Chemistry, ear canal secretion, or ear wax, contain chemical compounds which can be telltale signs of Parkinson's. During the study, researchers examined ear canal secretions from 209 people. About half (108 of the participants) had Parkinson's. In their examinations, scientists were able to identify four volatile organic compounds (VOC) that were notably different in those with the disease. Those compounds, or biomarkers, were ethylbenzene, 4-ethyltoluene, pentanal, and 2-pentadecyl-1,3-dioxolane. The scientists then trained an artificial intelligence olfactory (AIO) system on the biomarker data. And once training was complete, the AIO system was able to successfully determine which patients had Parkinson's and which did not. The system was accurate 94% of the time. Currently, Parkinson's is a tough disease to diagnose. According to Mayo Clinic, it requires expensive imaging, neurological tests, blood tests, genetic testing, and more. And often, a diagnosis is still often not conclusive. Likewise, treatment is a work-in-progress, with current therapies aimed at slowing progression rather than curing it. Therefore, ear wax testing could be a breakthrough first-step screening tool that's inexpensive, noninvasive, and accessible. The researchers who worked on the study say the findings are a major step in Parkinson's early detection, which currently, doesn't exist, but that more research is needed. 'This method is a small-scale single-center experiment in China,' study coauthor Hao Dong said in a press release. Hoa Dong continued, 'The next step is to conduct further research at different stages of the disease, in multiple research centers and among multiple ethnic groups, in order to determine whether this method has greater practical application value.'
New York Post
a day ago
- New York Post
Jenna Bush Hager reveals topless sunbathing once left her chest green — dermatologist reveals why
Here's another reason to slather on some SPF this summer — especially if you're planning to bare it all. Jenna Bush Hager revealed this week that a trip to a topless beach in Spain during high school left her so scorched, her chest turned green. 'If you get burned, it's not pretty,' the 43-year-old 'Today With Jenna & Friends' co-host told actress Leslie Bibb on Tuesday's episode. 5 Actress Leslie Bibb appeared on the June 16 episode of 'Today With Jenna & Friends.' NBC When Bibb, 51, asked if her chest peeled, Bush Hager nodded — but then took things in a bizarre turn. 'They may have turned green,' the TV personality said. 'The opposite of the color wheel!' 'They turned green? Are you for real life?' the White Lotus star gasped. 'Oh, I don't think that's good,' Bibb added — and she's probably right. Sunburns happen when you're exposed to too much ultraviolet (UV) light, which can penetrate into deep layers of the skin and cause cellular damage, according to the Mayo Clinic. The body responds by increasing blood flow to the area, leading to inflamed skin we know as a burn. 'Signs that your burns are significant include painful redness, peeling and blisters,' Dr. Lauren Taglia, a dermatologist, told Northwestern Medicine. In Bush Hager's case, her Elphaba-esque chest may have signaled something more serious going on beneath the surface. 5 Bush Hager's chest 'turned green' after a bad sunburn. NBC 5 'Green!' Bibb exclaimed. 'That… makes me sick.' TODAY with Jenna & Friends / TikTok 'When the skin barrier is significantly damaged from a bad sunburn, it's possible to develop a secondary bacterial infection,' Dr. Adarsh Vijay Mudgil, medical director of Mudgil Dermatology, told The Post. Mudgil hasn't treated Bush Hager personally, but he speculated that her symptoms could be caused by impetigo, a common and contagious bacterial skin infection. 'This can lead to the formation of yellowish-green crusts, which would explain the green color she described,' Mudgil explained. 'Impetigo can be painful and requires antibiotics for treatment, either topical or systemic, depending on how widespread the infection is,' he noted. Gross? Bush Hager agrees. 5 All skin types can burn, though those with a lighter complexion are more at risk. Evgen – The former first daughter said the experience was enough to scare her away from sunbathing for good. 'I try not, but this is years of sun damage,' she admitted, rubbing her arms and adding that she now gets regular skin checks. She also offered some sage advice for viewers: wear sunscreen, especially when you're young. 'SPF babies, SPF! Get hip with it!' Bibb chimed in. Dermatologists agree. For daily use, most experts recommend using sunscreen with an SPF of at least 30. If you're spending extended time outdoors, SPF 60 or higher is smart, according to Johns Hopkins Medicine. For full-body coverage, aim for about one ounce of sunscreen — roughly a shot glass. And don't forget to reapply every two hours, or more if you're swimming or sweating. Even if you're inside, you're not off the hook. 5 Hager Bush, a mom-of-three, wishes her younger self hadn't tanned so much. Instagram/jennabhager 'Most ultraviolet (UV) rays can penetrate glass, so if you're working or relaxing near a window, you're receiving sun exposure,' Dr. Elisabeth G. Richard, a dermatologist, told the Skin Cancer Foundation. The bright side: you won't have to reapply as frequently as you would outdoors, likely every four to six hours. 'Sun damage is cumulative,' Richard noted. 'So even if you're only exposed for a short time, it's important to have protection.' Experts also recommend doubling up with wide-brimmed hats, sunglasses and protective clothing for extra coverage. When the sun's at its peak — between 10 a.m. and 2 p.m. — your best bet is to head for the shade. And if a green chest isn't warning enough, don't forget: Every sunburn — even a mild one — increases your risk of skin cancer, including melanoma, the deadliest form of all. In fact, just one blistering burn in childhood or adolescence more than doubles your risk of melanoma later in life, according to the Skin Cancer Foundation. The American Cancer Society estimates that in 2025, 104,960 new melanoma cases will be diagnosed in the US — and 8,430 Americans will die from it.
